Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more
Eurofins Scientific SE (ERFSF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.220x
Based on the latest financial reports, Eurofins Scientific SE (ERFSF) has a cash flow conversion efficiency ratio of 0.220x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($789.30 Million) by net assets ($3.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Eurofins Scientific SE - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Eurofins Scientific SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Eurofins Scientific SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eurofins Scientific SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Far EasTone Telecommunications Co Ltd
TW:4904
|
0.087x |
|
Huadian Power International Corporation Limited
PINK:HPIFY
|
0.078x |
|
Healthcare Realty Trust Incorporated
NYSE:HR
|
0.024x |
|
Venture Global, Inc.
NYSE:VG
|
0.174x |
|
B2Gold Corp
NYSE MKT:BTG
|
0.080x |
|
GXO Logistics Inc
NYSE:GXO
|
-0.623x |
|
Hexcel Corporation
NYSE:HXL
|
0.100x |
|
ConvaTec Group Plc
PINK:CNVVF
|
0.182x |
Annual Cash Flow Conversion Efficiency for Eurofins Scientific SE (2002–2025)
The table below shows the annual cash flow conversion efficiency of Eurofins Scientific SE from 2002 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.58 Billion | $1.29 Billion | 0.361x | +47.44% |
| 2024-12-31 | $5.38 Billion | $1.32 Billion | 0.245x | +23.62% |
| 2023-12-31 | $5.14 Billion | $1.02 Billion | 0.198x | -15.41% |
| 2022-12-31 | $4.85 Billion | $1.14 Billion | 0.234x | -27.44% |
| 2021-12-31 | $4.68 Billion | $1.51 Billion | 0.323x | -1.95% |
| 2020-12-31 | $3.72 Billion | $1.22 Billion | 0.329x | +40.74% |
| 2019-12-31 | $2.90 Billion | $677.90 Million | 0.234x | +17.07% |
| 2018-12-31 | $2.72 Billion | $543.89 Million | 0.200x | +22.41% |
| 2017-12-31 | $2.48 Billion | $405.12 Million | 0.163x | -22.89% |
| 2016-12-31 | $1.76 Billion | $371.84 Million | 0.212x | -21.46% |
| 2015-12-31 | $1.08 Billion | $291.15 Million | 0.270x | -15.63% |
| 2014-12-31 | $664.24 Million | $212.17 Million | 0.319x | -25.54% |
| 2013-12-31 | $394.74 Million | $169.34 Million | 0.429x | +20.27% |
| 2012-12-31 | $376.12 Million | $134.16 Million | 0.357x | +3.57% |
| 2011-12-31 | $320.31 Million | $110.32 Million | 0.344x | -6.46% |
| 2010-12-31 | $230.69 Million | $84.94 Million | 0.368x | +16.19% |
| 2009-12-31 | $203.03 Million | $64.34 Million | 0.317x | +15.65% |
| 2008-12-31 | $219.12 Million | $60.04 Million | 0.274x | +49.26% |
| 2007-12-31 | $215.56 Million | $39.57 Million | 0.184x | -37.57% |
| 2006-12-31 | $102.64 Million | $30.18 Million | 0.294x | -4.93% |
| 2005-12-31 | $82.42 Million | $25.49 Million | 0.309x | -12.53% |
| 2004-12-31 | $66.10 Million | $23.37 Million | 0.354x | +44.47% |
| 2003-12-31 | $53.85 Million | $13.18 Million | 0.245x | +12.56% |
| 2002-12-31 | $52.91 Million | $11.51 Million | 0.217x | -- |